Lack of induced co-stimulation as a result of complement receptor 2 (CR2) ligation on mouse splenic B cells

International Immunology

Volumn 18, Issue 1, 2006, Pages 69-78

  Brown, Sheila L ^c   Barrault, Denise V ^a   Phythian Adams, Alex ^c   Knight, Andrew M ^b  

^a IMEX Business Centre   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Activation; Antigen processing presentation; BCR

Indexed keywords

B LYMPHOCYTE RECEPTOR; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR 2; LYMPHOCYTE ANTIGEN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; CROSS LINKING; FLUORESCENCE ACTIVATED CELL SORTING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; UPREGULATION;

ANIMALS; ANTIGEN PRESENTATION; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; RECEPTORS, COMPLEMENT 3D; SIGNAL TRANSDUCTION; SPLEEN;

EID: 30344452314     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxh350     Document Type: Article

References (56)

1. Lanzavecchia, A. 1985. Antigen-specific interaction between T and B cells. Nature 314:537.
2. Rock, K. L., Benacerraf, B. and Abbas, A. K. 1984. Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J. Exp. Med. 160:1102.
3. Patel, K. J. and Neuberger, M. S. 1993. Antigen presentation by the B cell antigen receptor is driven by the alpha/beta sheath and occurs independently of its cytoplasmic tyrosines. Cell 74:939.
4. Bonnerot, C., Lankar, D., Hanau, D. et al. 1995. Role of B cell receptor Ig alpha and Ig beta subunits in MHC class II-restricted antigen presentation. Immunity 3:335.
5. West, M. A., Lucocq, J. M. and Watts, C. 1994. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature 369:147.
6. Ferrari, G., Knight, A. M., Watts, C. et al. 1997. Distinct intracellular compartments involved in invariant chain degradation and antigenic peptide loading of major histocompatibility complex (MHC) class II molecules. J. Cell Biol. 139:1433.
7. Lennon-Dumenil, A. M., Bakker, A. H., Wolf-Bryant, P. et al. 2002. A closer look at proteolysis and MHC-class-II-restricted antigen presentation. Curr. Opin. Immunol. 14:15.
8. Peters, P. J., Neefjes, J. J., Oorschot, V. et al. 1991. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 349:669.
9. Amigorena, S., Drake, J. R., Webster, P. et al. 1994. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 369:113.
10. Pond, L., Kuhn, L. A., Teyton, L. et al. 1995. A role for acidic residues in di-leucine motif-based targeting to the endocytic pathway. J. Biol. Chem. 270:19989.
11. Wubbolts, R., Fernandez-Borja, M., Oomen, L. et al. 1996. Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surface. J. Cell Biol. 135:611.
12. Schwartz, R. H., Mueller, D. L., Jenkins, M. K. et al. 1989. T-cell clonal anergy. Cold Spring Harbor Symp. Quant. Biol. 54(Pt 2): 605.
13. Greenwald, R. J., Freeman, G. J. and Sharpe, A. H. 2004. The B7 family revisited. Annu. Rev. Immunol. 13:515.
14. Lenschow, D. J., Sperling, A. I., Cooke, M. P. et al. 1994. Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. J. Immunol. 153:1990.
15. Cooke, M. P., Heath, A. W., Shokat, K. M. et al. 1994. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J. Exp. Med. 179:425.
16. Stockinger, B., Zal, T., Zal, A. et al. 1996. B cells solicit their own help from T cells. J. Exp. Med. 183:891.
17. Macaulay, A. E., DeKruyff, R. H., Goodnow, C. C. et al. 1997. Antigen-specific B cells preferentially induce CD4+ T cells to produce IL-4. J. Immunol. 158:4171.
18. Lanzavecchia, A., Abrignani, S., Scheidegger, D. et al. 1988. Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets. J. Exp. Med. 167:345.
19. Carel, J., Myones, B., Frazier, B. et al. 1990. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection. J. Biol. Chem. 265: 12293.
20. Croix, D. A., Ahearn, J. M., Rosengard, A. M. et al. 1996. Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J. Exp. Med. 183:1857.
21. Fischer, M. B., Goerg, S., Shen, L. et al. 1998. Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science 280:582.
22. Boackle, S. A., Morris, M. A., Holers, V. M. et al. 1998. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells. J. Immunol. 161:6537.
23. Hess, M. W., Schwendinger, M. G., Eskelinen, E. L. et al. 2000. Tracing uptake of C3dg-conjugated antigen into B cells via complement receptor type 2 (CR2, CD21). Blood 95:2617.
24. Antoniou, A. N. and Watts, C. 2002. Antibody modulation of antigen presentation: Positive and negative effects on presentation of the tetanus toxin antigen via the murine B cell isoform of FcgammaRII. Eur. J. Immunol. 32:530.
25. Barrault, D. V. and Knight, A. M. 2004. Distinct sequences in the cytoplasmic domain of complement receptor 2 are involved in antigen internalization and presentation. J. Immunol. 172:3509.
26. Ross, T. M., Xu, Y., Bright, R. A. et al. 2000. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat. Immunol. 1:127.
27. Dempsey, P. W., Allison, M. E., Akkaraju, S. et al. 1996. C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity. Science 271:348.
28. Jacquier-Sarlin, M. R., Gabert, F. M., Villiers, M. B. et al. 1995. Modulation of antigen processing and presentation by covalently linked complement C3b fragment. Immunology 84:164.
29. Serra, V. A., Cretin, F., Pepin, E. et al. 1997. Complement C3b fragment covalently linked to tetanus toxin increases lysosomal sodium dodecyl sulfate-stable HLA-DR dimer production. Eur. J. Immunol. 27:2673.
30. Cherukuri, A., Cheng, P. C., Sohn, H. W. et al. 2001. The CD19/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts. Immunity 14:169.
31. Cherukuri, A., Cheng, P. C. and Pierce, S. K. 2001. The role of the CD19/ CD21 complex in B cell processing and presentation of complement-tagged antigens. J. Immunol. 167:163.
32. Prechl, J., Baiu, D. C., Horvath, A. et al. 2002. Modeling the presentation of C3d-coated antigen by B lymphocytes: Enhancement by CR1/ 2-BCR co-ligation is selective for the co-ligating antigen. Int. Immunol. 14:241.
33. Thornton, B. P., Vetvicka, V. and Ross, G. D. 1994. Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J. Immunol. 152:1727.
34. Boackle, S. A., Holers, V. M. and Karp, D. R. 1997. CD21 augments antigen presentation in immune individuals. Eur. J. Immunol. 27:122.
35. Thornton, B. P., Vetvicka, V. and Ross, G. D. 1996. Function of C3 in a humoral response: IC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells. Clin. Exp. Immunol. 104:531.
36. Kozono, Y., Abe, R., Kozono, H. et al. 1998. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells. J. Immunol. 160:1565.
37. Mongini, P. K. and Inman, J. K. 2001. Cytokine dependency of human B cell cycle progression elicited by ligands which coengage BCR and the CD21/CD19/CD81 costimulatory complex. Cell. Immunol. 207:127.
38. Mongini, P. K., Tolani, S., Fattah, R. J. et al. 2002. Antigen receptor triggered upregulation of CD86 and CD80 in human B cells: Augmenting role of the CD21/CD19 co-stimulatory complex and IL-4. Cell. Immunol. 216:50.
39. Takai, T., Ono, M., Hikida, M. et al. 1996. Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature 379:346.
40. Krop, I., de Fougerolles, A. R., Hardy, R. R. et al. 1996. Self-renewal of B-1 lymphocytes is dependent on CD19. Eur. J. Immunol. 26:238.
41. Dennert, G., Hyman, R., Lesley, J. et al. 1980. Effects of cytotoxic monoclonal antibody specific for T200 glycoprotein on functional lymphoid cell populations. Cell. Immunol. 53:350.
42. Germain, R. N., Bhattacharya, A., Dorf, M. E. et al. 1982. A single monoclonal anti-Ia antibody inhibits antigen-specific T cell proliferation controlled by distinct Ir genes mapping in different H-2 I subregions. J. Immunol. 128:1409.
43. Kinoshita, T., Takeda, J., Hong, K. et al. 1988. Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. J. Immunol. 140:3066.
44. Knight, A. M., Lucocq, J. M., Prescott, A. R. et al. 1997. Antigen endocytosis and presentation mediated by human membrane IgG1 in the absence of the Ig(alpha)/Ig(beta) dimer. EMBO J. 16:3842.
45. Barrault, D. V., Steward, M., Cox, V. F. et al. 2005. Efficient production of complement (C3d)3 fusion proteins using the baculovirus expression vector system. J. Immunol. Methods 304:158
46. Unkeless, J. C. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:580.
47. Whitmore, A. C., Haughton, G. and Arnold, L. W. 1996. Phenotype of B cells responding to the thymus-independent type-2 antigen polyvinyl pyrrolidinone. Int. Immunol. 8:533.
48. Tedder, T. F., Weis, J. J., Clement, L. T. et al. 1986. The role of receptors for complement in the induction of polyclonal B-cell proliferation and differentiation. J. Clin. Immunol. 6:65.
49. Kinoshita, T., Thyphronitis, G., Tsokos, G. C. et al. 1990. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor. Int. Immunol. 2:651.
50. Kroczek, R. A., Mages, H. W. and Hutloff, A. 2004. Emerging paradigms of T-cell co-stimulation. Curr. Opin. Immunol. 16:321.
51. Ling, V., Wu, P. W., Finnerty, H. F. et al. 2000. Cutting edge: identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor. J. Immunol. 164:1653.
52. Futagawa, T., Akiba, H., Kodama, T. et al. 2002. Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells. Int. Immunol. 14:275.
53. Nurieva, R. I., Mai, X. M., Forbush, K. et al. 2003. B7h is required for T cell activation, differentiation, and effector function. Proc. Natl Acad. Sci. USA 100:14163.
54. Liang, L., Porter, E. M. and Sha, W. C. 2002. Constitutive expression of the B7h ligand for inducible costimulator on naive B cells is extinguished after activation by distinct B cell receptor and interleukin 4 receptor-mediated pathways and can be rescued by CD40 signaling. J. Exp. Med. 196:97.
55. Heyman, B., Wiersma, E. J. and Kinoshita, T. 1990. In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody. J. Exp. Med. 172:665.
56. Muta, T., Kurosaki, T., Misulovin, Z. et al. 1994. A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signalling. Nature 368:70.